Moderna mRNA Vaccine
Manufacturing Facility

The local mRNA manufacturing capability will provide ready access to COVID-19 booster shots as well as mRNA vaccines for other respiratory viruses such as influenza and respiratory syncytial virus (RSV).

The Moderna facility will be Australia’s first large-scale mRNA vaccine manufacturing facility and is now under construction at Monash University in Melbourne.

The facility is expected to commence operations in 2024, subject to regulatory approvals. Once operational, it will produce up to 100 million vaccine doses every year. This will include COVID-19 booster shots as well as mRNA vaccines for other respiratory viruses such as influenza and respiratory syncytial virus (RSV). The local mRNA vaccine manufacturing capability will provide protection for Australians against future pandemics and will reduce our dependence on imported mRNA vaccines.

In our role, we provided comprehensive Hydraulic Services, covering various aspects such as cold water services, heated water services, non-drinking water services (including specialty laboratory systems, non-potable services, and more), sanitary plumbing systems, sanitary drainage systems, on-site liquid trade waste systems (encompassing laboratory plumbing, drainage, and on-site treatment), roof rainwater drainage, and downpipes, as well as stormwater drainage.

Additionally, our Fire Protection Services included fire sprinkler systems, fire hydrant systems, fire hose reel systems, portable fire extinguishers, fire detection and alarm systems, Building Occupant Warning System (BOWS), and gaseous suppression systems. Our role aimed at ensuring a comprehensive and efficient hydraulic and fire protection infrastructure for the project.